Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 59

1.

Increased intestinal permeability correlates with sigmoid mucosa alpha-synuclein staining and endotoxin exposure markers in early Parkinson's disease.

Forsyth CB, Shannon KM, Kordower JH, Voigt RM, Shaikh M, Jaglin JA, Estes JD, Dodiya HB, Keshavarzian A.

PLoS One. 2011;6(12):e28032. doi: 10.1371/journal.pone.0028032. Epub 2011 Dec 1.

2.

The regulatory role of α-synuclein and parkin in neuronal cell apoptosis; possible implications for the pathogenesis of Parkinson's disease.

Yasuda T, Mochizuki H.

Apoptosis. 2010 Nov;15(11):1312-21. doi: 10.1007/s10495-010-0486-8. Review.

PMID:
20221696
3.

[Clinical and pathological study on early diagnosis of Parkinson's disease and dementia with Lewy bodies].

Orimo S.

Rinsho Shinkeigaku. 2008 Jan;48(1):11-24. Review. Japanese.

PMID:
18386627
4.

Controlling the mass action of alpha-synuclein in Parkinson's disease.

Kim C, Lee SJ.

J Neurochem. 2008 Oct;107(2):303-16. doi: 10.1111/j.1471-4159.2008.05612.x. Epub 2008 Sep 2. Review.

5.

Modulation of alpha-synuclein aggregation by dopamine: a review.

Leong SL, Cappai R, Barnham KJ, Pham CL.

Neurochem Res. 2009 Oct;34(10):1838-46. doi: 10.1007/s11064-009-9986-8. Epub 2009 May 15. Review.

PMID:
19444607
6.

The Lewy body in Parkinson's disease: molecules implicated in the formation and degradation of alpha-synuclein aggregates.

Wakabayashi K, Tanji K, Mori F, Takahashi H.

Neuropathology. 2007 Oct;27(5):494-506. Review.

PMID:
18018486
7.
8.

Ubiquitination of alpha-synuclein and autophagy in Parkinson's disease.

Engelender S.

Autophagy. 2008 Apr;4(3):372-4. Epub 2008 Jan 18. Review.

PMID:
18216494
9.

Alpha-synuclein in peripheral tissues and body fluids as a biomarker for Parkinson's disease - a systematic review.

Malek N, Swallow D, Grosset KA, Anichtchik O, Spillantini M, Grosset DG.

Acta Neurol Scand. 2014 Aug;130(2):59-72. doi: 10.1111/ane.12247. Epub 2014 Apr 5. Review.

PMID:
24702516
10.

Targeting alpha-synuclein for the treatment of Parkinson's disease.

Rohn TT.

CNS Neurol Disord Drug Targets. 2012 Mar;11(2):174-9. Review.

PMID:
22483285
11.

Alpha-synuclein, lipids and Parkinson's disease.

Ruipérez V, Darios F, Davletov B.

Prog Lipid Res. 2010 Oct;49(4):420-8. doi: 10.1016/j.plipres.2010.05.004. Epub 2010 May 23. Review.

PMID:
20580911
12.

Physiological and pathological role of alpha-synuclein in Parkinson's disease through iron mediated oxidative stress; the role of a putative iron-responsive element.

Olivares D, Huang X, Branden L, Greig NH, Rogers JT.

Int J Mol Sci. 2009 Mar;10(3):1226-60. doi: 10.3390/ijms10031226. Epub 2009 Mar 17. Review.

13.

Metals, oxidative stress and neurodegenerative disorders.

Jomova K, Vondrakova D, Lawson M, Valko M.

Mol Cell Biochem. 2010 Dec;345(1-2):91-104. doi: 10.1007/s11010-010-0563-x. Epub 2010 Aug 22. Review.

PMID:
20730621
14.

The cellular pathology of Parkinson's disease.

Takahashi H, Wakabayashi K.

Neuropathology. 2001 Dec;21(4):315-22. Review.

PMID:
11837539
15.

[Lewy body formation in Parkinson's disease: neurodegeneration or neuroprotection?].

Wakabayashi K.

Rinsho Shinkeigaku. 2008 Nov;48(11):981-3. Review. Japanese.

PMID:
19198138
16.

Genes, proteins, and neurotoxins involved in Parkinson's disease.

von Bohlen und Halbach O, Schober A, Krieglstein K.

Prog Neurobiol. 2004 Jun;73(3):151-77. Review.

PMID:
15236834
17.

Interactions among alpha-synuclein, dopamine, and biomembranes: some clues for understanding neurodegeneration in Parkinson's disease.

Rochet JC, Outeiro TF, Conway KA, Ding TT, Volles MJ, Lashuel HA, Bieganski RM, Lindquist SL, Lansbury PT.

J Mol Neurosci. 2004;23(1-2):23-34. Review.

PMID:
15126689
18.
19.

α-Synuclein synaptic pathology and its implications in the development of novel therapeutic approaches to cure Parkinson's disease.

Bellucci A, Navarria L, Zaltieri M, Missale C, Spano P.

Brain Res. 2012 Jan 13;1432:95-113. doi: 10.1016/j.brainres.2011.11.031. Epub 2011 Nov 19. Review.

PMID:
22153624
20.

Beyond α-synuclein transfer: pathology propagation in Parkinson's disease.

Hansen C, Li JY.

Trends Mol Med. 2012 May;18(5):248-55. doi: 10.1016/j.molmed.2012.03.002. Epub 2012 Apr 13. Review.

PMID:
22503115
Items per page

Supplemental Content

Write to the Help Desk